# Ondansetron

NDC: 0409-0009
Generic name: ONDANSETRON
Labeler / Manufacturer: Hospira, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20241216

FDA application: ANDA077548

## Active ingredients

- ONDANSETRON HYDROCHLORIDE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0409-0009"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0409-0009
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d62cd60b-f87e-4825-bead-1d18bbc4e480